Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia
Guo‐Tian Ruan(Beijing Friendship Hospital), Hanping Shi(Beijing Shijitan Hospital), Jinyu Shi(Capital Medical University), Chunlei Hu(Capital Medical University), Hailun Xie(Guangxi Medical University), Mengmeng Song(China Pharmaceutical University), Xin Zheng(Union Hospital), Heyang Zhang(Academy of Military Medical Sciences), Chenan Liu(Hunan University of Technology), Yue Chen(Shanghai University of Engineering Science), Xiaoyue Liu(Zhejiang University), Li‐Chen Zhu(Guangxi Medical University), Minghua Cong(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Deng(Capital Medical University), Wen Hu(Tianjin University of Traditional Chinese Medicine), Xiaowei Zhang(Shanghai Medical College of Fudan University), Yi‐Zhong Ge(China International Science and Technology Cooperation), Ming Yang(Jiangsu University), Kunhua Wang(Yunnan University), Shiqi Lin(Nanjing University of Information Science and Technology)
Cited by 36
Related Papers
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study
|Frontiers in Immunology|2023|189
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
|Journal of Cachexia Sarcopenia and Muscle|2022|170
A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment
|Journal of Neuroinflammation|2020|167
A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer
|Frontiers in Endocrinology|2022|161
Inflammatory burden as a prognostic biomarker for cancer
|Clinical Nutrition|2022|152